External Ventricular Drain Market Size, Share, Opportunities, And Trends By Product (External Ventricular Drainage Set, Accessories), By Application (Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Other Non-traumatic Hydrocephalus Conditions), By End-User (Hospitals, Ambulatory Surgical Centers, Others), And By Geography - Forecasts From 2024 To 2029

The external ventricular drain market is projected to show steady growth during the forecast period. In neurosurgery, an external ventricular drain (EVD) is used to treat hydrocephalus and reduce excessive intracranial pressure (ICP). There are two main types of external ventricular drains (EVDs): conventional EVD and EVD with flow regulation of which the conventional EVD, which involves inserting a catheter into one of the brain's ventricles, is most commonly used. The major factors driving the market growth are the increasing incidence of neurological disorders, increased accident rates, and head injuries coupled with technological advancement in neurosurgery projects.

Market Drivers:

• The increasing incidence of neurological disorders anticipates the external ventricular drain market growth.

Neurological disorders are a group of illnesses that affect the nervous system, which includes the brain, spinal cord, nerves, and muscles. The symptoms of these disorders can vary widely depending on the specific area of the nervous system that is affected. According to the European Commission's Published article on “Brain Research” an enormous health concern is neurological illnesses. Around 165 million people in Europe suffer from a neurological disorder. It is estimated that one in three individuals may experience a neurological or mental disorder at some point in their lives. In addition to neurodegenerative illnesses like Parkinson's and Alzheimer's, brain disorders can also include epilepsy, depression, stroke, migraines, sleep disturbances, traumatic brain injury, pain syndromes, and addiction. With the growing prevalence of neurological disorders, the demand for extra ventricular drains for removing excessive fluid will also increase, thereby propelling the market growth.

• Increased accident rates and head injuries propel the external ventricular drain market growth.

Every year, around 1.19 million people die in car accidents, and 20 to 50 million get injured, many of whom end up with disabilities. A traumatic brain injury (TBI) refers to the disruption of the normal function of the brain, which can occur due to a penetrating head injury, a blow, jolt, or knock to the head. These types of injuries are a leading cause of mortality and disability and pose a serious threat to public health across the country. In 2020, there were 21,399 TBI-related emergency department visits, hospitalizations, or deaths in Tennessee. As accident rates increase, more people suffer brain injuries which can result in the need for EVD procedures and associated equipment. EVD is frequently used to treat diseases like hydrocephalus, which can be caused by head trauma. It can lead to a buildup of cerebrospinal fluid (CSF) and even death.

• Technological advancement in neurosurgery projects the external ventricular drain market growth.

Hydrocephalus is a medical condition where there is an excess of fluid in the brain, often caused by intracerebral hemorrhage. To treat this condition, doctors use trans frontal external ventricular drainage (EVD) along with OMMAYA sac implantation, which acts as a reservoir for continuous fluid removal or medication delivery, while the EVD permits fluid drainage. Laser guidance is used during surgery to ensure precise device placement, increasing efficiency and reducing the risk of complications. According to the National Library of Medicine, ten patients, with an average age of 58, underwent urgent surgery. All surgeries were completed according to the established requirements.

North America is predicted to continue its market dominance throughout the forecast period.

North America is anticipated to account for a significant share of the external ventricular drain market due to the rise in neurological disorders in regional economies and investment in research and development with respective hydrocephalus. For instance, according to a 2022 study by the Parkinson's Foundation, the annual number of Parkinson's disease diagnoses in America has risen by 50% to approximately 90,000, compared to the previously predicted rate of 60,000. During the study, it is expected that the North American market will experience growth due to the increasing prevalence of neurological disorders in the region. Treatment for hydrocephalus involves the use of external ventricular devices. These devices not only measure intracranial pressure but also aid in treating patients with severe head injuries by draining infected cerebrospinal fluid and reducing elevated intracranial pressure. In 2021, a $14 million grant was awarded to Johns Hopkins Medicine to support a clinical trial for hydrocephalus treatment efficacy by the National Institute of Neurological Disorders and Stroke (NINDS)

Market Restraints:

• Side effects will restrict the external ventricular drain market growth.

Several potential side effects, including infections, bleeding, catheter malfunctions, and misplacement, are associated with EVDs. These may necessitate additional surgeries, increasing healthcare costs and the risk of patient morbidity.

• Availability of non-invasive and minimally intrusive solutions restrains market growth.

Producers of EVD systems face increasing competition from emerging minimally invasive and non-invasive solutions for treating Traumatic Brain Injuries and hydrocephalus. To retain their market share and stay relevant, they need to highlight the unique benefits of their EVD systems, such as faster drainage and wider applicability.

Key Development:

• May 2023: Integra Life Sciences Holdings Corporation released an upgraded EVD system to provide better patient care and therapeutic advantages.

Segmentation

• By Product
  • External Ventricular Drainage Set
  • Accessories
• By Application
  • Traumatic Brain Injury
  • Subarachnoid Hemorrhage
  • Intracerebral Hemorrhage
  • Other Non-traumatic Hydrocephalus Conditions
• By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

1.8. Key Benefits for the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. EXTERNAL VENTRICULAR DRAIN MARKET BY PRODUCT 

5.1. Introduction

5.2. External Ventricular Drainage Set

5.2.1. Market Trends and Opportunities

5.2.2. Growth Prospects

5.3. Accessories 

5.3.1. Market Trends and Opportunities

5.3.2. Growth Prospects

6. EXTERNAL VENTRICULAR DRAIN MARKET BY APPLICATION 

6.1. Introduction

6.2. Traumatic Brain Injury

6.2.1. Market Trends and Opportunities

6.2.2. Growth Prospects

6.3. Subarachnoid Hemorrhage

6.3.1. Market Trends and Opportunities

6.3.2. Growth Prospects

6.4. Intracerebral Hemorrhage

6.4.1. Market Trends and Opportunities

6.4.2. Growth Prospects

6.5. Other Non-traumatic Hydrocephalus Conditions

6.5.1. Market Trends and Opportunities

6.5.2. Growth Prospects

7. EXTERNAL VENTRICULAR DRAIN MARKET BY END-USER

7.1. Introduction

7.2. Hospitals

7.2.1. Market Trends and Opportunities

7.2.2. Growth Prospects

7.3. Ambulatory Surgical Centers

7.3.1. Market Trends and Opportunities

7.3.2. Growth Prospects

7.4. Others

7.4.1. Market Trends and Opportunities

7.4.2. Growth Prospects

8. EXTERNAL VENTRICULAR DRAIN MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Product 

8.2.2. By Application

8.2.3. By End-User

8.2.4. By Country

8.2.4.1. United States

8.2.4.1.1. Market Trends and Opportunities

8.2.4.1.2. Growth Prospects

8.2.4.2. Canada

8.2.4.2.1. Market Trends and Opportunities

8.2.4.2.2. Growth Prospects

8.2.4.3. Mexico

8.2.4.3.1. Market Trends and Opportunities

8.2.4.3.2. Growth Prospects

8.3. South America

8.3.1. By Product 

8.3.2. By Application

8.3.3. By End-User

8.3.4. By Country 

8.3.4.1. Brazil

8.3.4.1.1. Market Trends and Opportunities

8.3.4.1.2. Growth Prospects

8.3.4.2. Argentina

8.3.4.2.1. Market Trends and Opportunities

8.3.4.2.2. Growth Prospects

8.3.4.3. Others

8.3.4.3.1. Market Trends and Opportunities

8.3.4.3.2. Growth Prospects

8.4. Europe

8.4.1. By Product 

8.4.2. By Application

8.4.3. By End-User

8.4.4. By Country

8.4.4.1. United Kingdom

8.4.4.1.1. Market Trends and Opportunities

8.4.4.1.2. Growth Prospects

8.4.4.2. Germany

8.4.4.2.1. Market Trends and Opportunities

8.4.4.2.2. Growth Prospects

8.4.4.3. France

8.4.4.3.1. Market Trends and Opportunities

8.4.4.3.2. Growth Prospects

8.4.4.4. Italy

8.4.4.4.1. Market Trends and Opportunities

8.4.4.4.2. Growth Prospects

8.4.4.5. Spain

8.4.4.5.1. Market Trends and Opportunities

8.4.4.5.2. Growth Prospects

8.4.4.6. Others

8.4.4.6.1. Market Trends and Opportunities

8.4.4.6.2. Growth Prospects

8.5. Middle East and Africa

8.5.1. By Product 

8.5.2. By Application

8.5.3. By End-User

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.1.1. Market Trends and Opportunities

8.5.4.1.2. Growth Prospects

8.5.4.2. UAE

8.5.4.2.1. Market Trends and Opportunities

8.5.4.2.2. Growth Prospects

8.5.4.3. Others

8.5.4.3.1. Market Trends and Opportunities

8.5.4.3.2. Growth Prospects

8.6. Asia Pacific

8.6.1. By Product 

8.6.2. By Application

8.6.3. By End-User

8.6.4. By Country

8.6.4.1. Japan

8.6.4.1.1. Market Trends and Opportunities

8.6.4.1.2. Growth Prospects

8.6.4.2. China

8.6.4.2.1. Market Trends and Opportunities

8.6.4.2.2. Growth Prospects

8.6.4.3. India

8.6.4.3.1. Market Trends and Opportunities

8.6.4.3.2. Growth Prospects

8.6.4.4. South Korea

8.6.4.4.1. Market Trends and Opportunities

8.6.4.4.2. Growth Prospects

8.6.4.5. Taiwan

8.6.4.5.1. Market Trends and Opportunities

8.6.4.5.2. Growth Prospects

8.6.4.6. Thailand

8.6.4.6.1. Market Trends and Opportunities

8.6.4.6.2. Growth Prospects

8.6.4.7. Indonesia

8.6.4.7.1. Market Trends and Opportunities

8.6.4.7.2. Growth Prospects

8.6.4.8. Others

8.6.4.8.1. Market Trends and Opportunities

8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Spiegelberg GmbH & Co. KG

10.2. Medtronic

10.3. Sophysa

10.4. Neuromedex GmbH

10.5. Integra LifeSciences

10.6. Möller Medical GmbH

10.7. B. Braun SE

10.8. Fuji Systems

10.9. Geistlich Pharma Inc.

Spiegelberg GmbH & Co. KG

Medtronic

Sophysa

Neuromedex GmbH

Integra LifeSciences

Möller Medical GmbH

B. Braun SE

Fuji Systems

Geistlich Pharma Inc.